𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Desmopressin inhibits lung and lymph node metastasis in a mouse mammary carcinoma model of surgical manipulation

✍ Scribed by Santiago Giron; Agueda M. Tejera; Giselle V. Ripoll; Daniel E. Gomez; Daniel F. Alonso


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
288 KB
Volume
81
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Contributions of vascularized lymph-node
✍ Leonard Weiss; Pamela M. Ward πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 469 KB

## Abstract Rats received hind‐foot‐web (FWI) injections of MT‐ 100‐TC mammary carcinoma cells; the resultant tumor metastasized first to the popliteal lymph nodes. Over the course of 4 weeks, in association with increases in tumor weight, the blood‐flow to the popliteal nodes increased 18‐fold, an

Lymph node metastasis in an animal model
✍ Nikolay R. Sapundzhiev; Anja A. DΓΌnne; Annette Ramaswamy; Helmut Sitter; R. Kim πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 258 KB

## Abstract ## Background and Objectives Endoscopic laser surgical resection of advanced squamous cell carcinoma (SCC) often requires division of the tumor into several pieces. It is unknown if this approach influences the incidence of regional and distant metastases. ## Study Design/Materials an

A Comparison of Survival and Disease-Spe
✍ David H. Garfield; Wilbur A. Franklin πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 62 KB πŸ‘ 1 views

T he recent article by Varlotto et al 1 raises issues that are prob- lematic in the recent and current bronchioloalveolar (BAC) literature. The third edition of the 1999 World Health Organization (WHO) consensus classification redefined BAC as an in situ tumor with a pure BAC growth pattern and with

A comparison of survival and disease-spe
✍ John M. Varlotto; John C. Flickinger; Abram Recht; Margaret C. Nikolov; Malcolm πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to assess whether disease‐specific survival (DSS) and overall survival (OS) differed among patients who had N1 and N2 bronchioloalveolar carcinoma (BAC) compared with patients who had non‐BAC nonsmall cell lung cancer (NSCLC). ## METHODS